Etripamil Nasal Spray Looks Promising for Self-Administered PSVT Treatment
Etripamil - Our Research & Dev - Milestone Pharma
Etripamil nasal spray may help resolve PSVT-related symptoms, says study
PDF) Etripamil Nasal Spray for Conversion of Repeated Spontaneous Episodes of Paroxysmal Supraventricular Tachycardia During Long‐Term Follow‐Up: Results From the NODE‐302 Study
PDF) Update on Etripamil Nasal Spray for the At-home Treatment of Acute Paroxysmal Supraventricular Tachycardia
HRS 2017: Could etripamil nasal spray be a “game-changer” for paroxysmal supraventricular tachycardia? - Cardiac Rhythm News
Etripamil Continues to Show Promise in Paroxysmal SVT: NODE-302 | tctmd.com
PDF] Etripamil Nasal Spray for Rapid Conversion of Supraventricular Tachycardia to Sinus Rhythm. | Semantic Scholar
Self-Administered Etripamil Safe, Effective for Paroxysmal Supraventricular Tachycardia
First Randomized, Multicenter, Placebo-Controlled Study of Self-Administered Intranasal Etripamil for Acute Conversion of Spontaneous Paroxysmal Supraventricular Tachycardia (NODE-301) | Circulation: Arrhythmia and Electrophysiology
A Nasal Spray for Rapid Heartbeat Disorder Could Be Best Option for Self-Treatment, Study Shows
Update on Etripamil Nasal Spray for the At-home Treatment of Acute Paroxysmal Supraventricular Tachycardia – touchCARDIO
Snortable drug that mends irregular heartbeat within 30 minutes could be rolled out next year | Daily Mail Online
Etripamil Nasal Spray for Rapid Conversion of Supraventricular Tachycardia to Sinus Rhythm - ScienceDirect
The role of self-administered intranasal etripamil in the management of SVT: the RAPID trial – BCS Heartbeat
Zolmitriptan Nasal Spray, Cipla Ltd, 0.7 ml at Rs 715/pack in Nagpur | ID: 21052926462
StudyPages - Study of Etripamil Nasal Spray for Patients With Paroxysmal Supraventricular Tachycardia
Etripamil Nasal Spray in Paroxysmal SVT Speeds Conversion to Sinus Rhythm: RAPID | tctmd.com
Nasal spray shows potential for quickly treating arrhythmia
Positive Results from ReVeRA Phase 2 Study of Etripamil Nasal Spray in AFib-RVR Presented by Milestone Pharmaceuticals during AHA 2023 | DAIC
Etripamil Nasal Spray Shows Promise for AF Patients With Rapid Ventricular Rate | tctmd.com
Experimental etripamil nasal spray great option for people with paroxysmal SVT
NODE clinical trials of Etripamil nasal spray for PSVT – All About Cardiovascular System and Disorders